Benzothiophene compounds, intermediates, compositions, and methods
    18.
    发明授权
    Benzothiophene compounds, intermediates, compositions, and methods 失效
    苯并噻吩化合物,中间体,组合物和方法

    公开(公告)号:US5998441A

    公开(公告)日:1999-12-07

    申请号:US552564

    申请日:1995-11-03

    摘要: A method for alleviating the symptoms of post-menopausal syndrome comprising administering to a woman in need thereof an effective amount of a compound of formula I ##STR1## wherein R.sup.1a is --H or --OR.sup.7a in which R.sup.7a is --H or a hydroxy protecting group;R.sup.2a is --H, halo, or --OR.sup.8a in which R.sup.8a is --H or a hydroxy protecting group;R.sup.3 is 1-piperidinyl, 1-pyrrolidino, methyl-1-pyrrolidinyl, dimethyl-1-pyrrolidino, 4-morpholino, dimethylamino, diethylamino, diisopropylamino, or 1-hexamethyleneimino;n is 2 or 3; andZ is --O--or --S--;or a pharmaceutically acceptable salt thereof, and further comprising administering to said woman an effective amount of estrogen.

    摘要翻译: 一种减轻绝经后综合症状的方法,包括向有需要的妇女施用有效量的式Ⅰ化合物,其中R 1a为-H或-OR 7a,其中R 7a为-H或羟基保护基; R2a是-H,卤素或-OR8a,其中R8a是-H或羟基保护基; R3是1-哌啶基,1-吡咯烷子基,甲基-1-吡咯烷基,二甲基-1-吡咯烷子基,4-吗啉代,二甲基氨基,二乙基氨基,二异丙基氨基或1-六亚甲基亚氨基; n为2或3; 并且Z是-O - 或-S-; 或其药学上可接受的盐,并且还包括向所述妇女施用有效量的雌激素。

    Benzothiophene compounds, intermediates, compositions, and methods
    20.
    发明授权
    Benzothiophene compounds, intermediates, compositions, and methods 失效
    苯并噻吩化合物,中间体,组合物和方法

    公开(公告)号:US5919800A

    公开(公告)日:1999-07-06

    申请号:US552890

    申请日:1995-11-03

    摘要: The present invention provides a method for inhibiting endometriosis comprising administering to a woman an effective amount of a compound of formula I ##STR1## wherein R.sup.1a is --H or --OR.sup.7a in which R.sup.7a is --H or a hydroxy protecting group;R.sup.2a is --H, halo, or --OR.sup.8a in which R.sup.8a is --H or a hydroxy protecting group;R.sup.3 is 1-piperidinyl, 1-pyrrolidino, methyl-1-pyrrolidinyl, dimethyl-1-pyrrolidino, 4-morpholino, dimethylamino, diethylamino, diisopropylamino, or 1-hexamethyleneimino;n is 2 or 3; andZ is --O-- or --S--;or a pharmaceutically acceptable salt thereof.

    摘要翻译: 本发明提供一种抑制子宫内膜异位症的方法,包括向女性施用有效量的其中R 1a为-H或-OR 7a的式I化合物,其中R 7a为-H或羟基保护基; R2a是-H,卤素或-OR8a,其中R8a是-H或羟基保护基; R3是1-哌啶基,1-吡咯烷子基,甲基-1-吡咯烷基,二甲基-1-吡咯烷子基,4-吗啉代,二甲基氨基,二乙基氨基,二异丙基氨基或1-六亚甲基亚氨基; n为2或3; Z为-O-或-S-; 或其药学上可接受的盐。